Borrelia IgG or IgM SeraSpot, Serum

Borrelia burgdorferi SeraSpot IgG; Borr. SeraSpot VlsE (B.b. afzelii) IgG; Borr. SeraSpot p39 (B.b. afzelii) IgG; Borr. SeraSpot p58 (B.b. garinii) IgG; Borr. SeraSpot p100 (B.b. afzelii) IgG; Borr. SeraSpot OspC (B.b. afzelii) IgG; Borr. SeraSpot OspC (B.b. garinii) IgG; Borr. SeraSpot OspC (B.b. sensu stricto) IgG; Borr. SeraSpot dbpA (B.b. afzelii) IgG; Borr. SeraSpot dbpA (B.b. garinii) IgG; Borr. SeraSpot dbpA (B.b. sensu stricto) IgG; Borrelia burgdorferi SeraSpot IgM; Borr. SeraSpot VlsE (B.b. afzelii) IgM; Borr. SeraSpot p39 (B.b. afzelii) IgM; Borr. SeraSpot p58 (B.b. garinii) IgM; Borr. SeraSpot p100 (B.b. garinii) IgM; Borr. SeraSpot OspC (B.b. afzelii) IgM; Borr. SeraSpot OspC (B.b. garinii) IgM; Borr. SeraSpot OspC (B.b. sensu stricto) IgM; Borr. SeraSpot dbpA (B.b. afzelii) IgM; Borr. SeraSpot dbpA (B.b. garinii) IgM; Borr. SeraSpot dbpA (B.b. sensu stricto) IgM

Serum

In general, the SeraSpot® has a higher sensitivity and specificity in detecting Borrelia antibodies compared to the ELISA and IFT test technique.

Source: https://www.arminlabs.com/en/tests/antibodies;Accessed 14-Sep-2017

New retrospective study confirming the Lyme SeraSpot® as a reliable and robust test system:
“Our evaluation data confirm that new multiplex assay generations such as SeraSpot ® Anti-BorreliaIgG/IgM are reliable and robust test systems suitable for application as confirmatory tests for serodiagnosis of Lyme borreliosis. “Von Baehr et al.: Evaluation of a New Multiparametric Microspot Array for Serodiagnosis of Lyme Borreliosis in: Clin. Lab. 2015;61

The SeraSpot® MicroArray analyzes the following Borrelia burgdorferi IgG- and IgM-antibodies and Borrelia burgdorferi subspecies:
VlsE (B.b. afzelii), p39 (B.b. afzelii), p58 (B.b. garinii), p100 (B.b. afzelii), OspC (B.b. afzelii + B.b. garinii + B.b. sensu stricto), DbpA (B.b. afzelii + B.b. garinii + B.b. sensu stricto).